ACTIVATED AND INTERFERON-GAMMA PRODUCING THYROID-DERIVED T-CELLS ARE DETECTED IN GRAVES-DISEASE, THYROID AUTONOMY AS WELL AS IN NONTOXIC MULTINODULAR GOITER
G. Aust et al., ACTIVATED AND INTERFERON-GAMMA PRODUCING THYROID-DERIVED T-CELLS ARE DETECTED IN GRAVES-DISEASE, THYROID AUTONOMY AS WELL AS IN NONTOXIC MULTINODULAR GOITER, European journal of endocrinology, 135(1), 1996, pp. 60-68
The relative numbers of activated and interferon gamma (IFN-gamma)-pro
ducing peripheral blood lymphocytes (PBL) and thyroid-derived lymphocy
tes (TL) were determined using double surface and intracellular labeli
ng techniques in flow cytometry. Cells were analyzed from 10 patients
with Graves' disease (GD), eight patients with thyroid autonomy (TA) a
nd five patients with non-toxic multinodular goiter (NTG). A maximum o
f 1% IFN-gamma(-) cells were detected both in unstimulated PBL and TL.
Stimulation caused a two- to threefold higher number of IFN-gamma(+)
cells in TL (GD, 48 +/- 12%; TA, 48 +/- 11%; NTG, 50 +/- 15%) as compa
red to PBL (GD, 15 +/- 7%; TA, 16 +/- 8%; NTG, 18 +/- 10%) of the same
patients. Nearly all IFN-gamma(+) TL in GD were CD3(+) T cells, where
as 10-20% of IFN-gamma(+) TL in TA and NTG were NI( cells, In PBL 80%
and in TL almost 100% of IFN-gamma(+) cells were antigen-primed CD45RO
(+) cells. Only 25-35% of IFN-gamma(+) thyroid-derived T cells express
ed the CD4 antigen. About 42 +/- 10% thyroid-derived T cells in GD, 33
+/- 11% in TA and 34 +/- 13% in NTG expressed the HLA-DR molecule but
not the interleukin 2 (CD25) or the transferrin receptor (CD71), Fort
y per cent of these HLA-DR(+) T cells showed an intracellular staining
for IFN-gamma and half of them co-expressed the activation antigen CD
69. Immunofluorescence double labeling on thyroid cryostat sections de
monstrated that HLA-DR(+) T cells were also present in situ, The prese
nce of activation antigens on thyroid-derived T cells not only in pati
ents with GD but also in TA and NTG suggests failsafe mechanisms such
as anergy, suppression or cytokine regulation in so-called non-immunog
enic goiter.